表紙
市場調查報告書

遺傳基因放大技術的全球市場

Gene Amplification Technologies

出版商 Global Industry Analysts, Inc. 商品編碼 912402
出版日期 內容資訊 英文 293 Pages
商品交期: 最快1-2個工作天內
價格
遺傳基因放大技術的全球市場 Gene Amplification Technologies
出版日期: 2020年10月01日內容資訊: 英文 293 Pages
簡介

本報告提供全球遺傳基因放大技術市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 簡介·調查手法·調查範圍

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球市場的企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 日本
    • 加拿大
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ABBOTT MOLECULAR
  • AGILENT TECHNOLOGIES, INC.
  • CEPHEID
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • EPPENDORF AG
  • F. HOFFMANN-LA ROCHE AG
  • GE HEALTHCARE
  • PERKINELMER INC.
  • PROMEGA CORPORATION
  • QIAGEN NV
  • ROCHE DIAGNOSTICS CORPORATION
  • Sysmex
  • TaKaRa BIO

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1102

Accurate Results from Small Samples. Dominance of PCR Based COVID-19 Tests Gives Gene Amplification a 31.7% Boost

The global market for Gene Amplification Technologies is forecast to witness revenues spike by over 31.7% in the year 2020 and thereafter continue to grow to reach US$6.8 billion by the year 2027, trailing a post COVID-19 CAGR of 11.4% over the analysis period 2020 through 2027. Gene amplification typically uses Polymerase Chain Reaction (PCR) which remains the most commonly used and effective technology since it permits researchers to obtain lots of gene replicas quickly. Fueled by the introduction of novel PCR instruments for the detection of several critical diseases, Polymerase Chain Reaction (PCR) continues to dominate the gene amplification market. Polymerase chain reaction technology was introduced to the market in 1980s. The technology is used to detect the type and amount of virus or bacteria present in biological samples and also allows amplification of genetic material in large quantities.

In the midst of the ongoing pandemic, diagnostic and antibody tests hold a critical role in identifying people with COVID-19 infection to support isolation or quarantine measures. These tests are expected to help governments in rapidly identifying and isolating infected people and tracking contacts to manage the situation. Molecular diagnostic tests available on the market rely on RT-PCR technology to target specific genomic parts of the virus for accurate, reliable detection. PCR-based techniques are capable of detecting low quantities of viral RNA to deliver high sensitivity and allow timely diagnosis of the COVID-19 infection. Current growth in the gene amplification market is therefore being driven by qPCR technique, closely followed by RT-PCR (Reverse Transcription PCR), the two most widely used testing technologies for COVID-19 disease. A lion's share of the millions of COVID-19 tests performed worldwide is accounted for by PCR based tests. Polymerase Chain Reaction (PCR) remains the most commonly used & effective technology for gene amplification as the technology permits researchers to create lots of gene replicas very quickly. The technology allows amplification of genetic material in large quantities and is cost-effective & has a rapid turnover rate. 10 months into the pandemic & with infections continuing to spread, the focus on testing, testing & testing promises to raise revenue potential for the technology by a massive 31.7% in the year 2020. Regionally, North America represents the largest market for PCR and is expected to retain its dominance, with the US remaining the single largest market.

The market also stands to benefit from the growing popularity of molecular diagnostics for cancer screening and infectious disease testing such as hepatitis B and C, HIV, flu virus and human papilloma virus. According to the W.H.O, more than 10 million people are expected to die of cancer by the year 2026. The market for oncology-specific molecular diagnostics is dominated by breast cancer, which has a share of 15% in the overall test volumes. There are several commercialized molecular diagnostic products available for breast cancer. Fastest growth in future however is expected to be reported by colorectal cancer. Molecular diagnostic markets for prostate cancer and liver cancer are also anticipated to see major growth in the coming years due to increasing prevalence of these cancer types. People suffering from various infectious diseases, such as GI, STDs, and respiratory diseases are also increasing in numbers. These grave statistics, though alarming, represent growth drivers for the latest diagnostic techniques and devices, including molecular diagnostics based on gene amplification. PCR assays detect the presence of organisms such as Chlamydia, mycoplasmas, mycobacteria, Herpes viruses and enteroviruses from clinical specimens. Commercial PCR assays for the diagnosis of tuberculosis and C. trachomatis infection are routinely used in diagnostic laboratories. PCR assay also detects antimicrobial resistance and are used to identify the cause of infection.

Competitors identified in this market include, among others,

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Charles River Laboratories International, Inc.
  • Eppendorf AG
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Roche Diagnostics Corporation
  • Sysmex Corporation
  • Takara Bio, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • A Prelude to Gene Amplification
    • Gene Amplification Technologies Market Poised to Register Rapid Growth
    • Polymerase Chain Reaction (PCR) - The Most Widely used Gene Amplification Technology
    • US Dominates the Gene Amplification Market
    • Rise in COVID-19 Cases Drives the Demand for Gene Amplification Technologies
    • EXHIBIT 1: Top Countries Affected by COVID-19 Outbreak: Total Cases and Cases Per Million Population
    • COVID-19 and the Diagnostics
    • COVID-19 Diagnostic Test Platforms
    • Fighting the COVID-19 War with Molecular Diagnostics
    • Introduction to COVID-19 Testing
    • Diagnostic Tests
    • Molecular Tests
    • Antigen Tests
    • Antibody Tests
    • RT-PCR Emerges as an Effective Test to Combat COVID-19 Pandemic
    • RT-LAMP Assays Present Opportunity to Fast-Track and Push COVID-19 Testing
  • WORLD BRANDS
  • 2. FOCUS ON SELECT PLAYERS
    • Recent Market Activity
    • Innovations & Advancements
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Number of Genomics Projects Propels Market Growth
    • Genomic Initiatives in Select Countries
    • EXHIBIT 2: Total VC Funding (In US$ Million) in Genetics for the Years 2014, 2015, 2016, 2017 and 2018
    • Advances in Genome Sequencing to Spur the Gene Amplification Market
    • Molecular Diagnostics Progress to Increase Demand for Gene Amplification Technologies
    • Factors Driving Molecular Diagnostics Market
    • Oncology Molecular Diagnostics to Witness Rapid Growth
    • PCR Technology Leads the MDx Market
    • Prospects for Genetic Diagnostics and Testing Grow Brighter
    • List of Select FDA-Cleared Genetic Tests by Disease
    • Increasing Incidence of Infectious Diseases Results in Increased Demand for Gene Amplification Technologies
    • PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
    • Emergence of LAMP as Alternative to RT-PCR
    • Advanced DNA Amplification Technique Works at Body Temperature
    • Burgeoning Geriatric Population - A Key Demand Driver for Gene Amplification Technologies
    • EXHIBIT 3: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020 & 2025
    • Growing Incidence of Hospital Acquired Infections Propels Market Growth
    • Advent of Isothermal DNA Amplification Techniques
    • Isothermal Amplification Method Gaining Traction in Field Applications
    • Loop-Mediated Isothermal Amplification
    • New CRISPR-Based System
    • Gene Amplification Plays Pivotal Role in Diagnosing Inherited Conditions
    • Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
    • PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents
    • Increase in Number and Complexity of Foodborne Outbreaks: Food Safety Testing Market Positioned for Growth
    • Foodborne Illness Outbreak Investigations in the US (2019 & 2020)
    • An Insight into Food Safety Testing Market by Technology
    • Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing
    • Growing Concerns over GMOs Demand Rapid Tests for GMOs Detection
    • Status of Ban on GMO Corps in Select Countries
    • PCR Technique Plays a Vital Role in GMOs Detection
    • Technology Advancements
    • Advanced DNA Amplification Technique Works at Body Temperature
    • New England Biolabs Launches Rapid Colorimetric LAMP Assay Kit to Expedite COVID-19 Diagnostic Testing to Just 30 Minutes
    • Molecular Diagnostics in Water and Food Safety Analysis-Existing Challenges and New Developments
    • Molecular Diagnostics-Future Applications
    • Commercialized Isothermal Amplification Methods for Water and Food Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Gene Amplification Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Gene Amplification Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Gene Amplification Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Medical & Pharma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Medical & Pharma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Medical & Pharma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Forensic & Identity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Forensic & Identity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Forensic & Identity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Agricultural & Food Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Agricultural & Food Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Agricultural & Food Safety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • US Witnesses Strong Wave of New Diagnostic Tests amid COVID-19 Pandemic
    • Rising Cancer Cases Spur Growth in Gene Amplification Technology Market
    • EXHIBIT 4: Estimated Number of New Cancer Cases and Deaths in the US (2019)
    • Growing Molecular Diagnostics Market Drives the Demand for Gene Amplification Technologies
    • Rapidly Ageing Population: A Major Driving Demand for Gene Amplification Technologies
    • EXHIBIT 5: North American Elderly Population by Age Group (1975-2050)
    • EXHIBIT 6: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population
    • Market Analytics
    • TABLE 16: USA Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 17: USA Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 18: USA 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • CANADA
    • High Focus on Improving Healthcare Augurs Well for Market Growth
    • EXHIBIT 7: Number of New Cancer Cases in Canada: 2019
    • Market Analytics
    • TABLE 19: Canada Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 20: Canada Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 21: Canada 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • JAPAN
    • Increasing Need for Geriatric Healthcare and Cancer Care to Drive Demand for Gene Amplification Market
    • EXHIBIT 8: Japanese Population by Age Group (2015 & 2040): Percentage Share Breakdown of Population for 0-14, 15-64 and 65 & Above Age Groups
    • EXHIBIT 9: Cancer Related Incidence and Deaths by Site in Japan: 2018
    • Market Analytics
    • TABLE 22: Japan Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 23: Japan Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 24: Japan 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • CHINA
    • Rising Cancer Incidence Drives the Gene Amplification Market
    • EXHIBIT 10: Number of New Cancer Cases Diagnosed (in Thousands) in China: 2018
    • Market Analytics
    • TABLE 25: China Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 26: China Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 27: China 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • EUROPE
    • Rising Cancer Incidence Drives the European Gene Amplification Market
    • EXHIBIT 11: Cancer Incidence in Europe: Number of New Cancer Cases (in Thousands) by Site for 2018
    • Market Analytics
    • TABLE 28: Europe Current & Future Analysis for Gene Amplification Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 29: Europe Historic Review for Gene Amplification Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 30: Europe 15-Year Perspective for Gene Amplification Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 31: Europe Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 32: Europe Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 33: Europe 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 34: France Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 35: France Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 36: France 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 37: Germany Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 38: Germany Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 39: Germany 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 40: Italy Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 41: Italy Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 42: Italy 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 43: UK Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: UK Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 45: UK 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: Rest of Europe Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 48: Rest of Europe 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • Growing Incidence of Cancer in Asia-Pacific to Propel the Demand for Gene Amplification Market
    • EXHIBIT 12: Cancer Incidence in Asia: Number of New Cancer Cases (in Thousands) for 2019
    • Market Analytics
    • TABLE 49: Asia-Pacific Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: Asia-Pacific Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 51: Asia-Pacific 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 52: Rest of World Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: Rest of World Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 54: Rest of World 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 52